COVID-19 Response Team, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, Georgia.
JAMA Intern Med. 2022 Jul 1;182(7):701-709. doi: 10.1001/jamainternmed.2022.1827.
As self-collected home antigen tests become widely available, a better understanding of their performance during the course of SARS-CoV-2 infection is needed.
To evaluate the diagnostic performance of home antigen tests compared with reverse transcription-polymerase chain reaction (RT-PCR) and viral culture by days from illness onset, as well as user acceptability.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted from January to May 2021 in San Diego County, California, and metropolitan Denver, Colorado. The convenience sample included adults and children with RT-PCR-confirmed infection who used self-collected home antigen tests for 15 days and underwent at least 1 nasopharyngeal swab for RT-PCR, viral culture, and sequencing.
SARS-CoV-2 infection.
The primary outcome was the daily sensitivity of home antigen tests to detect RT-PCR-confirmed cases. Secondary outcomes included the daily percentage of antigen test, RT-PCR, and viral culture results that were positive, and antigen test sensitivity compared with same-day RT-PCR and cultures. Antigen test use errors and acceptability were assessed for a subset of participants.
This study enrolled 225 persons with RT-PCR-confirmed infection (median [range] age, 29 [1-83] years; 117 female participants [52%]; 10 [4%] Asian, 6 [3%] Black or African American, 50 [22%] Hispanic or Latino, 3 [1%] Native Hawaiian or Other Pacific Islander, 145 [64%] White, and 11 [5%] multiracial individuals) who completed 3044 antigen tests and 642 nasopharyngeal swabs. Antigen test sensitivity was 50% (95% CI, 45%-55%) during the infectious period, 64% (95% CI, 56%-70%) compared with same-day RT-PCR, and 84% (95% CI, 75%-90%) compared with same-day cultures. Antigen test sensitivity peaked 4 days after illness onset at 77% (95% CI, 69%-83%). Antigen test sensitivity improved with a second antigen test 1 to 2 days later, particularly early in the infection. Six days after illness onset, antigen test result positivity was 61% (95% CI, 53%-68%). Almost all (216 [96%]) surveyed individuals reported that they would be more likely to get tested for SARS-CoV-2 infection if home antigen tests were available over the counter.
The results of this cohort study of home antigen tests suggest that sensitivity for SARS-CoV-2 was moderate compared with RT-PCR and high compared with viral culture. The results also suggest that symptomatic individuals with an initial negative home antigen test result for SARS-CoV-2 infection should test again 1 to 2 days later because test sensitivity peaked several days after illness onset and improved with repeated testing.
随着自我采集的家用抗原检测变得广泛可用,我们需要更好地了解它们在 SARS-CoV-2 感染过程中的表现。
通过从发病开始的天数,评估家用抗原检测与逆转录聚合酶链反应(RT-PCR)和病毒培养相比的诊断性能,以及用户的接受程度。
设计、地点和参与者:这是一项前瞻性队列研究,于 2021 年 1 月至 5 月在加利福尼亚州圣地亚哥县和科罗拉多州丹佛大都市区进行。便利样本包括经 RT-PCR 确认感染的成年人和儿童,他们使用自我采集的家用抗原检测进行了 15 天,并至少进行了 1 次鼻咽拭子的 RT-PCR、病毒培养和测序。
SARS-CoV-2 感染。
主要结局是家用抗原检测每天检测到 RT-PCR 确诊病例的敏感性。次要结局包括抗原检测、RT-PCR 和病毒培养结果阳性的每日百分比,以及与同日 RT-PCR 和培养物相比的抗原检测敏感性。对一部分参与者进行了抗原检测使用错误和可接受性的评估。
本研究纳入了 225 名经 RT-PCR 确诊感染的患者(中位数[范围]年龄,29[1-83]岁;117 名女性参与者[52%];10[4%]亚裔,6[3%]非裔美国人,50[22%]西班牙裔或拉丁裔,3[1%]夏威夷原住民或其他太平洋岛民,145[64%]白人,11[5%]多种族个体),他们完成了 3044 次抗原检测和 642 次鼻咽拭子。抗原检测的敏感性在感染期为 50%(95%CI,45%-55%),与同日 RT-PCR 相比为 64%(95%CI,56%-70%),与同日培养物相比为 84%(95%CI,75%-90%)。抗原检测的敏感性在发病后第 4 天达到峰值,为 77%(95%CI,69%-83%)。抗原检测的敏感性随着随后 1 至 2 天的第二次抗原检测而提高,尤其是在感染早期。发病后第 6 天,抗原检测结果阳性率为 61%(95%CI,53%-68%)。几乎所有(216[96%])接受调查的个人报告说,如果家用抗原检测可以在柜台购买,他们更有可能接受 SARS-CoV-2 感染检测。
这项关于家用抗原检测的队列研究结果表明,与 RT-PCR 相比,SARS-CoV-2 的敏感性适中,与病毒培养相比,敏感性较高。结果还表明,最初 SARS-CoV-2 感染的家用抗原检测结果为阴性的有症状个体,应在 1 至 2 天后再次检测,因为检测敏感性在发病后数天达到峰值,并随着重复检测而提高。